|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 378.00 EUR | -0.63% |
|
-0.18% | +3.14% |
| 20/07 | No Gucci, no problem? Coty learns to live without flagship brand | RE |
| 09/07 | LOREAL : JP Morgan remains Neutral | ZD |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.23TCr | 3.83TCr | 4.12TCr | 4.35TCr | 4.41TCr | |||||
Total Revenues | 3.23TCr | 3.83TCr | 4.12TCr | 4.35TCr | 4.41TCr | |||||
Cost of Goods Sold, Total | 843.33Cr | 1.06TCr | 1.08TCr | 1.12TCr | 1.13TCr | |||||
Gross Profit | 2.39TCr | 2.77TCr | 3.04TCr | 3.23TCr | 3.27TCr | |||||
Selling General & Admin Expenses, Total | 1.67TCr | 1.91TCr | 2.1TCr | 2.22TCr | 2.25TCr | |||||
R&D Expenses | 102.87Cr | 113.86Cr | 128.89Cr | 135.47Cr | 138.06Cr | |||||
Other Operating Expenses, Total | 1.77TCr | 2.02TCr | 2.23TCr | 2.36TCr | 2.39TCr | |||||
Operating Income | 615.03Cr | 745.03Cr | 814.11Cr | 867.66Cr | 888.29Cr | |||||
Interest Expense, Total | -3.8Cr | -7.04Cr | -23Cr | -37Cr | -37Cr | |||||
Interest And Investment Income | 40Cr | 54Cr | 58Cr | 59Cr | 52Cr | |||||
Net Interest Expenses | 36Cr | 47Cr | 36Cr | 22Cr | 15Cr | |||||
Income (Loss) On Equity Invest. | 6L | 14L | 2L | -13L | -55L | |||||
Other Non Operating Income (Expenses) | -3.01Cr | -6.58Cr | -4.66Cr | -2.58Cr | -2.9Cr | |||||
EBT, Excl. Unusual Items | 647.96Cr | 785.35Cr | 845.1Cr | 886.93Cr | 900.22Cr | |||||
Restructuring Charges | -15Cr | -5.8Cr | -8.85Cr | -24Cr | -21Cr | |||||
Merger & Related Restructuring Charges | -1.43Cr | - | -4.6Cr | -2.07Cr | -4.95Cr | |||||
Impairment of Goodwill | -25Cr | - | -25Cr | - | - | |||||
Gain (Loss) On Sale Of Assets | -4L | -12Cr | -67L | -1.52Cr | -3.77Cr | |||||
Asset Writedown | -8.28Cr | -3.9Cr | -2.06Cr | -5.08Cr | - | |||||
Legal Settlements | 4.56Cr | - | - | -9.99Cr | - | |||||
Other Unusual Items | 2.42Cr | -2.25Cr | -3.81Cr | -1.4Cr | -21Cr | |||||
EBT, Incl. Unusual Items | 604.76Cr | 761.2Cr | 800.11Cr | 843.16Cr | 849.68Cr | |||||
Income Tax Expense | 144.54Cr | 189.94Cr | 181.06Cr | 201.51Cr | 236.31Cr | |||||
Earnings From Continuing Operations | 460.22Cr | 571.26Cr | 619.05Cr | 641.65Cr | 613.37Cr | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 460.22Cr | 571.26Cr | 619.05Cr | 641.65Cr | 613.37Cr | |||||
Minority Interest | -51L | -60L | -65L | -78L | -65L | |||||
Net Income - (IS) | 459.71Cr | 570.66Cr | 618.4Cr | 640.87Cr | 612.72Cr | |||||
Net Income to Common Incl Extra Items | 459.71Cr | 570.66Cr | 618.4Cr | 640.87Cr | 612.72Cr | |||||
Net Income to Common Excl. Extra Items | 459.71Cr | 570.66Cr | 618.4Cr | 640.87Cr | 612.72Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 8.24 | 10.65 | 11.55 | 11.99 | 11.48 | |||||
Basic EPS - Continuing Operations | 8.24 | 10.65 | 11.55 | 11.99 | 11.48 | |||||
Basic Weighted Average Shares Outstanding | 56Cr | 54Cr | 54Cr | 53Cr | 53Cr | |||||
Net EPS - Diluted | 8.21 | 10.61 | 11.52 | 11.95 | 11.44 | |||||
Diluted EPS - Continuing Operations | 8.21 | 10.61 | 11.52 | 11.95 | 11.44 | |||||
Diluted Weighted Average Shares Outstanding | 56Cr | 54Cr | 54Cr | 54Cr | 54Cr | |||||
Normalized Basic EPS | 7.25 | 9.15 | 9.85 | 10.36 | 10.53 | |||||
Normalized Diluted EPS | 7.23 | 9.12 | 9.82 | 10.33 | 10.5 | |||||
Dividend Per Share | 4.8 | 6 | 6.6 | 7 | 7.2 | |||||
Payout Ratio | 51.16 | 47.14 | 55.39 | 56.41 | 63.93 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 692.71Cr | 829.1Cr | 900.96Cr | 964.2Cr | 989.45Cr | |||||
EBITA | 622.06Cr | 746.45Cr | 821.23Cr | 873.61Cr | 893.59Cr | |||||
EBIT | 615.03Cr | 745.03Cr | 814.11Cr | 867.66Cr | 888.29Cr | |||||
Effective Tax Rate - (Ratio) | 23.9 | 24.95 | 22.63 | 23.9 | 27.81 | |||||
Total Current Taxes | 136.17Cr | 199.59Cr | 190.59Cr | 205.25Cr | 229.49Cr | |||||
Total Deferred Taxes | 8.36Cr | -9.65Cr | -9.53Cr | -3.74Cr | 6.82Cr | |||||
Normalized Net Income | 404.46Cr | 490.24Cr | 527.54Cr | 553.55Cr | 561.99Cr | |||||
Non-Cash Pension Expense | -1.55Cr | -91L | -1.13Cr | 21L | 33L | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 1.06TCr | 1.21TCr | 1.34TCr | 1.4TCr | 1.42TCr | |||||
Selling and Marketing Expenses | 1.06TCr | 1.21TCr | 1.34TCr | 1.4TCr | 1.42TCr | |||||
Research And Development Expense From Footnotes | 102.87Cr | 113.86Cr | 128.89Cr | 135.47Cr | 138.06Cr | |||||
Stock-Based Comp., Other (Total) | 16Cr | 17Cr | 17Cr | 24Cr | 25Cr | |||||
Total Stock-Based Compensation | 16Cr | 17Cr | 17Cr | 24Cr | 25Cr |
- Stock Market
- Stocks
- OR Stock
- Financials L'Oréal
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















